Two-Year Follow-Up Study on Neurodevelopmental Outcomes After Term Intrapartum Asphyxia Using...
-
Upload
mulyono-aba-athiya -
Category
Documents
-
view
214 -
download
0
Transcript of Two-Year Follow-Up Study on Neurodevelopmental Outcomes After Term Intrapartum Asphyxia Using...
-
7/29/2019 Two-Year Follow-Up Study on Neurodevelopmental Outcomes After Term Intrapartum Asphyxia Using Questionaire
1/8
http://jcn.sagepub.com/Journal of Child Neurology
http://jcn.sagepub.com/content/early/2012/10/18/0883073812461564The online version of this article can be found at:
DOI: 10.1177/0883073812461564
published online 30 October 2012J Child NeurolZarrin Keihani-Doust, Maryam Saeedi, Tahere Esmaeilni, Massoud Habibi and Seyed Saeed Hashemi NazariAge and Stages Questionnaire
o-Year Follow-Up Study on Neurodevelopmental Outcomes After Term Intrapartum Asphyxia Us
Published by:
http://www.sagepublications.com
can be found at:Journal of Child NeurologyAdditional services and information for
http://jcn.sagepub.com/cgi/alertsEmail Alerts:
http://jcn.sagepub.com/subscriptionsSubscriptions:
http://www.sagepub.com/journalsReprints.navReprints:
http://www.sagepub.com/journalsPermissions.navPermissions:
What is This?
- Oct 30, 2012OnlineFirst Version of Record>>
at UNIVERSITAS GADJAH MADA on September 21, 2013jcn.sagepub.comDownloaded from at UNIVERSITAS GADJAH MADA on September 21, 2013jcn.sagepub.comDownloaded from at UNIVERSITAS GADJAH MADA on September 21, 2013jcn.sagepub.comDownloaded from at UNIVERSITAS GADJAH MADA on September 21, 2013jcn.sagepub.comDownloaded from at UNIVERSITAS GADJAH MADA on September 21, 2013jcn.sagepub.comDownloaded from at UNIVERSITAS GADJAH MADA on September 21, 2013jcn.sagepub.comDownloaded from at UNIVERSITAS GADJAH MADA on September 21, 2013jcn.sagepub.comDownloaded from at UNIVERSITAS GADJAH MADA on September 21, 2013jcn.sagepub.comDownloaded from
http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/content/early/2012/10/18/0883073812461564http://jcn.sagepub.com/content/early/2012/10/18/0883073812461564http://www.sagepublications.com/http://jcn.sagepub.com/cgi/alertshttp://jcn.sagepub.com/cgi/alertshttp://jcn.sagepub.com/subscriptionshttp://jcn.sagepub.com/subscriptionshttp://jcn.sagepub.com/subscriptionshttp://www.sagepub.com/journalsReprints.navhttp://www.sagepub.com/journalsReprints.navhttp://www.sagepub.com/journalsPermissions.navhttp://online.sagepub.com/site/sphelp/vorhelp.xhtmlhttp://online.sagepub.com/site/sphelp/vorhelp.xhtmlhttp://online.sagepub.com/site/sphelp/vorhelp.xhtmlhttp://jcn.sagepub.com/content/early/2012/10/18/0883073812461564.full.pdfhttp://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://online.sagepub.com/site/sphelp/vorhelp.xhtmlhttp://jcn.sagepub.com/content/early/2012/10/18/0883073812461564.full.pdfhttp://www.sagepub.com/journalsPermissions.navhttp://www.sagepub.com/journalsReprints.navhttp://jcn.sagepub.com/subscriptionshttp://jcn.sagepub.com/cgi/alertshttp://www.sagepublications.com/http://jcn.sagepub.com/content/early/2012/10/18/0883073812461564http://jcn.sagepub.com/ -
7/29/2019 Two-Year Follow-Up Study on Neurodevelopmental Outcomes After Term Intrapartum Asphyxia Using Questionaire
2/8
Original Article
Two-Year Follow-Up Study onNeurodevelopmental Outcomes AfterTerm Intrapartum Asphyxia Using Age
and Stages Questionnaire
Zarrin Keihani-Doust, MD1
, Maryam Saeedi, MD, MPH1
,Tahere Esmaeilni, MD1, Massoud Habibi, MD2, and
Seyed Saeed Hashemi Nazari, MD, MPH, PhD3
Abstract
Birth asphyxia is one of the multiple causes of neonatal encephalopathy. The objective of this study was to evaluate neurode-
velopmental outcomes of newborn term infants with definitive asphyxia. Thirty infants met study criteria for asphyxia. The 5-yearincidence of asphyxia was estimated to be 5.5 in 1000. According to the Age and Stage Questionnaire, 10.5% of 6-month-oldinfants, 14.3% of 12- and 18-month-old infants, and 5.3% of 24-month-old infants had neurodevelopmental delay in gross motorfunction in the absence of cerebral palsy. In 7.3% of 18-month-old infants, neurodevelopmental delay in problem-solving abilitywas observed. Higher values of Apgar score and bicarbonate levels were associated with higher Age and Stage Questionnaire
total score. Delivery type, maternal age, gravidity of mother, and existence of mother disease during pregnancy were alsoassociated with lower Age and Stage Questionnaire total score in different stages of life.
Keywords
neurodevelopmental delay, Age and Stage Questionnaire, Apgar, asphyxia, term infant, encephalopathy
Received June 18, 2012. Accepted for publication August 27, 2012.
Encephalopathy is the result of brainmalfunction that can be clas-
sified as acute versus chronic or stable versus progressive. About
80% of full-term infants with encephalopathy have acute injuries,
3% have nonhypoxic ischemia and less than 1% have prenatal
injuries. Different disorders in mother can cause fetal hypoxia,
including low maternal blood pressure, inadequate oxygenation
of maternal blood, inadequate relaxation of uterus caused by
excessive administration of oxytocin, premature separation of
placenta, placental insufficiency, and compression of cord.1
Birth asphyxia is one of the multiple causes of neonatal ence-
phalopathy.2 Although in some studies these 2 terms are consid-
ered the same, in the literature on neonatal encephalopathy, once
infants with major malformations, drugs, metabolic causes, and
infections are excluded, the remaining cases are assumed to be
asphyxia related.3 Hypoxic-ischemic encephalopathy is
classified according to assessment of feeding, alertness, tone,
body posture, tendon reflexes, myoclonus, Moro reflex, cornea
situation, duration of signs, and electroencephalogram (EEG)
abnormalities into 3 stages. The prognosis of stage 1 is good.
Stage 2 has varied prognosis and stage 3 or persistence of stage
2 for more than 7 days or failure of EEG to revert to normal is
associated with neurodevelopmental impairment or death.
Expected outcomes for a term newborn with intrapartum
asphyxia are normality, death, or a neurodevelopmental
disability.4
Hypoxic-ischemic encephalopathy usually occurs in 1 to 2
per 1000 newborn infants.5 Almost, 20% of infants with
hypoxic-ischemic encephalopathy die during infancy and
25% suffer from permanent neurodevelopmental impairment.
To our knowledge, few studies have been done on the neu-
rodevelopmental function of term infant with asphyxia in
developing countries and in our country this study is the first
1 Department of Pediatrics, Imam Hospital, Tehran University of Medical
Sciences, Tehran, Iran2 Iranian center for Breast Cancer, Academic Center for Education, Culture
and Research, Tehran, Iran3 Department of Epidemiology and Biostatistics, Tehran University of Medical
Sciences, School of public Health, Tehran, Iran
Corresponding Author:
Maryam Saeedi, MD, MPH, Department of Pediatrics, Imam Hospital, Tehran
University of Medical Sciences, Gharib Street, Keshavarz Boulevard, Tehran,
Iran
Email: [email protected]
Journal of Child Neurology
00(0) 1-7
The Author(s) 2012
Reprints and permission:
sagepub.com/journalsPermissions.nav
DOI: 10.1177/0883073812461564
http://jcn.sagepub.com
-
7/29/2019 Two-Year Follow-Up Study on Neurodevelopmental Outcomes After Term Intrapartum Asphyxia Using Questionaire
3/8
in this field. The objective of our study was to evaluate neuro-
developmental outcomes of a cohort of newborn term infants
with defined asphyxia. These outcomes were measured by Age
and Stages Questionnaire.
MethodsStudy Population
All deliveries were scanned in a university-based pediatric hospital
between 2007 and 2011 in the capital city of Iran, Tehran. Infants who
met our criteria for definition of intrapartum hypoxia and were born at
term (ie, greater than 36 weeks gestation) were enrolled in a prospec-
tive cohort study with a 24-month follow-up. Infants who suffered
from metabolic diseases or congenital abnormalities were excluded
from this study.
Asphyxia Definition
There is not any global agreement on definition of asphyxia. Our
review literature showed that 3 sets of criteria are used mostly fordiagnosis of asphyxia. According to the American Academy of
Pediatrics and the American College of Obstetrics and Gynecology
in 1996,6
intrapartum hypoxia was defined by profound acidosis (cord
pH
-
7/29/2019 Two-Year Follow-Up Study on Neurodevelopmental Outcomes After Term Intrapartum Asphyxia Using Questionaire
4/8
38.7 weeks; 26.7% had 37 weeks, 23.3% had 38 weeks, 16.7%
had 39 weeks, 20% had 40 weeks, and 13.3% had more than 40
weeks. Twenty-five infants (83.3%) received positive-pressure
ventilation at the time of delivery, 20% received cardiac resusci-
tation, and for 20% intratracheal intubation was performed. From
these infants, 23.3% had seizures within 3 days following the
delivery. Imaging studies wereperformed on the neonate who had
clinical signs of hypoxia. Brain ultrasonography was performed
on 24 infants and brain computed tomography was performed
on 7 infants. Acute asphyxia changes including intraventricular
hemorrhage, periventricular leukomalacia, choroid plexus cyst
and ventriculomegaly were observed in 5 ultrasonographic and
3 computed tomographic scans.
Of 30 infants with asphyxia, 3 (10%) died (2 on the first day
and 1 on the 19th day of life). There was a statistically
significant association between seizure (P .009), intubation
(P .005), and abnormal finding in brain ultrasonography
(P .022) and death outcome. We could not find any signifi-
cant differences in the pH level, base deficit, and the Apgar
score of infants who died in comparison to other infants.
Age and Stage Questionnaire Scores in 6-Month-OldInfants
All the infants received higher than the cut-off score in commu-
nication, fine motor function, problem-solving ability, and
personal-social area. In 10.5% of infants, gross motor function
was lower than the cut-off score. To define the predictors of
neurodevelopmental outcomes, the association of the total
score of the Age and Stage Questionnaire and the score in each
of the 5 neurodevelopmental areas and maternal and neonatal
variables were evaluated in separate univariate regression
models. From maternal and neonatal variables, Apgar score and
bicarbonate levels in blood were associated positively with the
total Age and Stage Questionnaire Score and the base deficit was
associated negatively with the total Age and Stage Questionnaire
score. The results of fitted models are presented in Table 2. Age
and Stage Questionnaire scores of each of the 5 neurodevelop-
ment areas were also regressed on maternal and neonatal
variables.
The communication score was not associated with any of the
defined maternal and neonatal variables. The gross motor score
was associated positively with the Apgar score. The fine motor
score was associated negatively with delivery type (cesarean
section vs normal vaginal delivery), gravidity of mother, and
mother disease during pregnancy. The problem-solving ability
score was associated negatively with the base deficit and
positively with the bicarbonate level. The personal-social score
was associated positively with the Apgar score and the bicarbo-nate level and negatively with the base deficit. The results of
fitted models are presented in Table 3.
Age and Stage Questionnaire Scores in 12-Month-Old
Infants
All the infants received higher than the cut-off score in commu-
nication, fine motor function, problem-solving ability, and
personal-social area. In 14.3% of infants, gross motor function
was lower than the cut-off score. Again, separate univariate
models were fitted to define the maternal and neonatal vari-ables that affect the Age and Stage Questionnaire score. From
the maternal and neonatal variables, the mean bicarbonate level
of the blood samples was associated positively with the total
Age and Stage Questionnaire score and the base deficit was
negatively associated. The results of fitted models are
presented in Table 2.
The communication score was associated positively with
positive-pressure ventilation. The gross and fine motor scores
were associated negatively with base deficit and positively with
the bicarbonate level. The problem-solving ability score and
the personal-social score were associated negatively with birth
weight. The results of fitted models are presented in Table 3.
Age and Stage Questionnaire Scores in 18-Month-Old
Infants
In this age, only the gross motor function and problem-solving
abilities were abnormal in 14.3% and 7.1% of infants respec-
tively. Univariate analysis of the neonatal and maternal factors
showed a positive effect for Apgar score on the Age and Stage
Questionnaire score. The maternal age and the mothers disease
during pregnancy demonstrated a negative effect. For a 5-year
increment in mothers age, the Age and Stage Questionnaire
score decreased by 4.25 points. The infants of mothers who had
a disease during pregnancy, had, on average, an Age and Stage
Questionnaire Score that was 14 points less than other infants.
The results of fitted models are presented in Table 2.
The communication score was associated negatively with the
existence of a disease inside the mother during pregnancy. The
gross motor score was associated positively with bicarbonate
levels. The fine motor score was not associated with any of the
defined maternal and neonatal variables. The problem-solving
ability score was associated negatively with base deficit and posi-
tively with bicarbonate levels. The personal-social score was not
associated with any of the defined maternal and neonatal
variables. The results of fitted models are presented in Table 3.
Table 1. Numbers of Infants With Each of the Inclusion Criteria
Inclusion criteria n (%)
Range
AverageMin Max
Cord blood pH 12 13 (43.3) 21 4.7 12.25-minute Apgar scores
-
7/29/2019 Two-Year Follow-Up Study on Neurodevelopmental Outcomes After Term Intrapartum Asphyxia Using Questionaire
5/8
Age and Stage Questionnaire Scores in 24-Month-Old
Infants
At this stage, just the gross motor function was under the
cut-off limit in 5.3% of infants and all other neurodevelopmen-
tal areas were normal. Univariate analysis showed a positive
association between Age and Stage Questionnaire Score and
bicarbonate levels and a negative weak association between
base deficit and the Age and Stage Questionnaire Score. The
results of fitted models are presented in Table 2. The commu-
nication score was associated negatively with the mother
disease during pregnancy and positively with positive pressure
ventilation. The gross motor score was associated positively
with the Apgar score and negatively with maternal age and
maternal disease. The fine motor score was not associated with
any of the defined maternal and neonatal variables. The
problem-solving ability score was associated negatively with
the base deficit and the mothers disease and positively with the
Apgar score and seizure occurrence in infants. The personal-
social score was associated negatively with the childs birth
weight. The results of fitted models are presented in Table 3.
Discussion
Intrapartum asphyxia is only one of the many possible causes
of neonatal encephalopathy.12 Approximately 15% to 20% of
infants with neonatal encephalopathy will die during the new-
born period, and 25% of the survivors will sustain permanent
clinical deficits.5 Only 10% of infants with evidence of hypoxic
ischemic encephalopathy develop cerebral palsy.13 In our
study, 3 of 30 infants with asphyxia (10%) died. The lack of
an objective marker of term intrapartum asphyxia has clouded
efforts to clinically diagnose intrapartum asphyxia and to
understand its potential range of adverse outcomes.
Some studies have shown that in the absence of cerebral
palsy, a neurodevelopmental disability is a relatively common
consequence of term intrapartum asphyxia, which occurs in
approximately 41.5% of patients.12
Some other studies have documented much lower
prevalence for a variety of adverse neurologic outcomes,
including motor, cognitive, memory, language, learning, and
behavioral deficits and limitations that may reach the threshold
for the diagnosis of a specific neurodevelopmental disability(including global developmental delay, mental retardation or
intellectual disability, attention deficit hyperactivity disorder,
learning disabilities, developmental language impairment,
autistic spectrum disorders, epilepsy, and secondary microce-
phaly) in absence of cerebral palsy in term intrapartum
asphyxia.4,5
In the current study, 10.5% of 6-month-old infants, 14.3% of
12- and 18-month-old infants and 5.3% of 24-month-old
infants had neurodevelopmental delay in gross motor function
in the absence of cerebral palsy. In 7.3% of 18-month-old
infants, neurodevelopmental delay in problem solving ability
was observed. These findings are in accordance with other
studies in this field.5,12
Prior studies have shown that clinical and biochemical
variables, such as umbilical artery blood gases or Apgar scores,
are of limitedvalue in predicting neurodevelopmental outcomes.5
In our study, a higher value of Apgar score was a predictor of
higher Age and Stage Questionnaire total score and also better
gross motor and personal-social function and problem-solving
ability. Higher level of bicarbonate was also a predictor of higher
total Age and Stage Questionnaire score and better gross and fine
motor function, problem-solving ability, and personal-social
function. Base deficit was associated negatively with Age and
Stage Questionnaire total score and also gross motor, personal-
social function and problem solving ability.
Table 2. Regression of Age and Stage Questionnaire Total Scores on Maternal and Neonatal Factors in 6-, 12-, 18-, and 24-Month-Old Infants
6th month 12th month 18th month 24th monthCoeff. (95% CI) Coeff. (95% CI) Coeff. (95% CI) Coeff. (95% CI)
Sex 1.6 (5.7, 8.8) 3.7 (6.3, 13.6) 4.2 (6.7, 15.0) 0.7 (5.4, 4.1)Maternal age 0.3 (0.9, 0.2) 0.5 (1.3, 0.3) 0.9 (1.6, 0.1)* 0.0 (0.4, 0.4)
Gestational age 2.0 (0.1, 4.1) 2.2 (-1.0, 5.4) 1.8 (1.9, 5.4) 0.2 (1.3, 1.6)Birth weight 1.2 (6.3, 4.0) 4.5 (10.8, 1.9) 2.0 (9.4, 5.5) 0.5 (2.3, 3.3)Delivery type 4.1 (9.9, 1.7) 3.7 (11.9, 4.4) 6.0 (14.4, 2.5) 0.3 (4.1, 4.6)Gravidity 0.4 (5.4, 4.5) 0.2 (10.4, 10.1) 3.5 (14.4, 7.4) 0.2 (2.6, 3.0)Mother disease during pregnancy 4.1 (10.5, 2.4) 5.0 (16.6, 6.6) 14.1 (23.7, 4.5)** 8.1 (16.5, 0.3)Meconium-stained liquor 1.7 (8.0, 11.3) 0.8 (17.1, 15.4) 1.0 (16.8, 18.8) 1.6 (7.3, 4.1)Apgar score in fifth minute 1.9 (0.2, 3.7)* 2.0 (0.5, 4.4) 2.8 (0.4, 5.2)* 0.4 (2.7, 1.8)pH 16.5 (9.9, 43.0) 29.8 (12.3, 71.9) 15.9 (33.3, 65.2) 11.3 (37.4, 14.8)Base deficit 0.7 (0.1, 1.3)* 1.0 (0.2, 1.9)* 0.7 (0.4, 1.8) 0.6 (0.0, 1.2)*Bicarbonate level 0.7 (0.2, 1.3)* 1.2 (0.3, 2.1)* 0.8 (0.4, 2.0) 0.6 (0.0, 1.2)*Positive pressure ventilation 2.4 (9.1, 4.2) 0.7 (10.9, 9.5) 2.2 (8.9, 13.3) 1.2 (4.5, 6.9)Chest compression 4.8 (12.5, 3.0) 2.7 (14.5, 9.2) 3.6 (16.5, 9.3) 0.3 (9.0, 9.7)Intubation 3.2 (4.8, 11.2) 6.7 (9.0, 22.4) 5.3 (12.1, 22.8) 0.3 (9.0, 9.7)Seizure 2.0 (10.1, 6.1) 3.1 (13.2, 6.9) 5.6 (16.2, 5.0) 0.0 (5.8, 5.7)
*P < .05, **P < .01, ***P < .001.
4 Journal of Child Neurology 00(0)
-
7/29/2019 Two-Year Follow-Up Study on Neurodevelopmental Outcomes After Term Intrapartum Asphyxia Using Questionaire
6/8
T
able3.RegressionofAgeandStageQuestionnaireScoreinEachof5Neurode
velopmentalAreasonMaternalandNe
onatalFactorsat6-,12-,18-,and24-Mo
nth-OldInfants
N
eurodevelopmental
ar
eas
6thm
onth
12thmo
nth
18thmo
nth
24thm
onth
Variable
Coeff.
(95%CI)
Variable
Coeff.
(95%CI)
Variable
Coeff.
(95%CI)
Variable
Coeff.
(95%CI)
C
ommunication
Positivepressure
ventilation
3
9.2
(2.1,
16.4
)*
Motherdisease
22.9(38.7,7.2
)**
Motherdisease
49.4
(54.6,44.3
)***
Positivepressure
ventilation
3
16.0
(2.5,
29.5
)*
G
rossmotor
Apgarscore
5.3
(1.4,
9.3
)*
Apgarscore
7.3
(0.9,
13.7
)*
Motherage
1.7
(3.1,0.3
)*
Bicarbonatelevel
1.0
(0.2,
1.9
)*
BaseDeficit
2.8
(0.2,5.4
)*
Motherdisease
21.3
(42.5,0.0
02)*
Bicarbonatelevel
3.1
(0.3,
5.9
)*
Apgarscore
6.6(2.6,
10.5
)**
Fi
nemotor
Delivery
7.7
(14.1,1.4
)*
BaseDeficit
1.4
(0.5,2.3
)**
Gravidity
6.4
(11.5,1.3
)*
Bicarbonatelevel
1.2
(0.0,
2.4
)*
Motherdisease
7.7
(14.9,0.5
)*
Problem
solving
BaseDeficit
0.9
(0.1,1.7
)*
Birthweight
5.3
(8.8,1.8
)**
BaseDeficit
1.6
(0.2,2.9
)*
Bicarbonatelevel
1.0
(0.3,
1.8
)**
Motherdisease
17.1
(32.1,2.1
)*
BaseDeficit
1.4
(0.5,
2.2
)**
Apgarscore
4.6
(1.5,
7.6
)**
Bicarbonatelevel
1.1
(0.2,
2.1
)*
Seizure
14.4
(27.3,1.5
)*
Personal-social
Apgarscore
3.2
(1.0,
5.4
)**
Birthweight
5.2
(9.0,1.4
)*
Birthweight
4.0
(7.9,0.1
)*
BaseDeficit
1.1
(0.3,1.8
)*
Bicarbonatelevel
1.2
(0.5,
1.9
)**
*P